Scientists from a US-based biotech firm plan to trigger the nervous system of brain-dead patients to ‘revive’ their brains. And, guess what, they have been granted ethical permission to do so.
Company Bioquark wants to stimulate the dead back to life, or something along these lines. The project called ReAnima will be made possible thanks to the grant that was issued by an Institutional Review Board in the US and India. The researchers will thus be able to conduct their work on a group of 20 patients.
“To undertake such a complex initiative, we are combining biologic regenerative medicine tools with other existing medical devices typically used for stimulation of the central nervous system, in patients with other severe disorders of consciousness,” says the CEO of Bioquark, Ira Pastor, in a statement to The Telegraph.
The experiments to be carried out include various therapies to which the patients will be subjected. It is to be noted that these patients have been certified to be brain-dead by experts; they are sustained through life support machines.
One of the attempts of the scientists will be to inject the patients with spinal cord infusions consisting of the necessary chemicals. Nerve stimulation techniques will also be included, and the researchers intend to use stem cells on the brains which might thus be protected from degeneration; being in a coma is associated with brain degeneration, and adding stem cells might lead to the differentiation of new specialised cells.
After applying these techniques, the team will look out for any brain activity of the patients. For instance, they hope that they might be able to neurologically reactivate the patients. Of course, all of this is easier said than done, but, the team is expecting to generate results within the first few months of their experiments.
The first trials will start in India, at the Anupam Hospital in Uttarakhand. Pastor is positive that these patients might one day fully recover.